IntraCellular Therapies (ITCI)
(Real Time Quote from BATS)
$65.28 USD
+0.28 (0.43%)
Updated May 20, 2024 03:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Intra-Cellular Therapies Inc. [ITCI]
Reports for Purchase
Showing records 1 - 20 ( 23 total )
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for ITCI 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department